about
Hepatic late adverse effects after treatment for childhood cancerLiver-Directed Radiotherapy for Hepatocellular CarcinomaModulation of Radiation Response by the Tetrahydrobiopterin PathwayRadioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveGiant solitary fibrous tumour of the liverLiver metabolomics reveals increased oxidative stress and fibrogenic potential in gfrp transgenic mice in response to ionizing radiationHelical tomotherapy for single and multiple liver tumoursRadiation therapy for liver tumors: ready for inclusion in guidelines?Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation TherapyHuman CD34+ cells mobilized by granulocyte colony-stimulating factor ameliorate radiation-induced liver damage in miceComparison of the dosimetries of 3-dimensions Radiotherapy (3D-RT) with linear accelerator and intensity modulated radiotherapy (IMRT) with helical tomotherapy in children irradiated for neuroblastoma.New progress of non-surgical treatments for hepatocellular carcinoma.Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model.Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop.Hepatocyte growth factor gene therapy prevents radiation-induced liver damage.Radiation-Induced Liver Injury in Three-Dimensional Conformal Radiation Therapy (3D-CRT) for Postoperative or Locoregional Recurrent Gastric Cancer: Risk Factors and Dose Limitations.Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seedSafety evaluation of 32P-chromic phosphate-poly L lactic acid particles interstitially implanted into livers of Beagle dogs.Therapeutic Potential of Adjuvant Stereotactic Body Radiotherapy for Gallbladder CancerLocal and Global Function Model of the LiverTherapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinomaIncreased mortality rates in young and middle-aged patients with malignant germ cell tumours.A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images.Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy.Challenge and hope in radiotherapy of hepatocellular carcinomaEndovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus.Nonsurgical options for hepatocellular carcinoma: evolving role of external beam radiotherapy.Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.Brachytherapy with Iodine-125 seeds strand for treatment of main portal vein tumor thrombi: an experimental study in a rabbit modelFeasibility of 4D perfusion CT imaging for the assessment of liver treatment response following SBRT and sorafenibInduction of Lipocalin2 in a Rat Model of Lung Irradiation.Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients.Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients.A20 enhances the radiosensitivity of hepatocellular carcinoma cells to 60Co-γ ionizing radiation.Dosimetric and clinical effects of interfraction and intrafraction correlation errors during marker-based real-time tumor tracking for liver SBRT.Role and Future Directions of External Beam Radiotherapy for Primary Liver Cancer.A knowledge-based approach to automated planning for hepatocellular carcinoma.Strategies for prediction and mitigation of radiation-induced liver toxicity.The Feasibility and Efficiency of Volumetric Modulated Arc Therapy-Based Breath Control Stereotactic Body Radiotherapy for Liver Tumors.
P2860
Q24239880-1E8E7AFC-C639-4F94-B311-795BE0E09938Q26738869-687330C0-6AA6-4D17-BAD7-96C24F46900AQ26770958-B3F8D119-D019-4DCF-9814-3E831E346E7DQ26998661-EC9FA6BE-AECC-4563-8215-99DE1C84D67BQ33264228-9CCC924D-81C4-4A84-86FD-3020B1BBB87CQ33740134-9D6EBAD0-6975-4A7A-BF54-FB2CB31B7824Q33975859-27713895-D539-4BA4-8FC4-C146F577DA9CQ34005194-9CB5C282-3FAF-4AFA-9777-4C25E1A2F7A7Q34118056-1D776535-74DB-4AFF-A725-D6654071FD14Q34135216-6C30D81F-DEEC-4A29-AB31-5829D06F4601Q34319964-16955291-0C34-42E0-91C1-AD89EFFB6701Q34647076-283F4192-95F6-4C0A-B68A-28E8CC4B9146Q34689652-5B7E4EA4-9AF0-4D25-9BA3-CBF788556FC8Q34913450-EC6E8443-D6E3-43EB-BB5A-861EFCBD32F5Q35010438-4020C85B-1B9F-4AC2-BEAC-F3B427063A04Q35751290-9BF79D07-ADD2-46A5-A609-CA2A7CB7FF63Q35760916-A35476B2-0011-48DB-9AED-E378C97C3793Q35831893-4D21B550-D204-4FBE-BADA-B5FB7C53F8F4Q36067376-7F360CC5-FDD7-4567-9ABE-31368B7CCDB6Q36407143-D511BAC0-1A9E-4216-8D25-19B27988CFA3Q36496500-CC02EF9B-4C5E-444D-85A8-525BF94F5394Q36694603-1BAEF81A-5A6E-419F-9F24-877BA4862A6CQ36798881-9BC592B2-8B22-40AC-B18B-60DC53A26EBCQ36914411-56674168-BA96-44B0-9BEF-2977793608AAQ37356887-2BB12CBC-1816-4F6B-80E6-058336420C2FQ37400936-BB414A86-4AA6-4FF5-B14A-950020818D0EQ37707056-8C97424B-932B-4CE2-88D3-7122F21B6600Q37734194-F6476133-9F3F-4341-83AE-F4EDF996BE51Q38538075-08F8288F-5855-47BC-8CB3-E7A4E23C16EDQ40836748-CED7002F-0D1B-4A82-9DF1-10AC2EC7B2E2Q41038300-6D7A4DB3-CB96-4C75-85D9-E2D5D010D62AQ42759715-46A62B4A-86D5-4545-AF59-5BFE2DF26CFBQ45828457-37EB1393-9F7C-4486-A3CA-C2FF9C217ADCQ46430969-2F6A7AFC-1AA8-453A-A615-89C693173699Q47107783-948DAB81-4D3C-4661-84B1-794CA0BBA040Q47290163-6B65A08F-83B2-4A38-98FC-54D34F972A4AQ47869234-FD11E3FC-5F28-42D3-B413-7C8B2055FB56Q50010696-C2B726E5-8A8C-4F3F-B2A7-30541FAAEE82Q50061872-763256ED-70BF-4CF6-A351-27B03AD429D5Q51610207-899F010C-CF95-49D5-BACC-F8AE3526B8A9
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Partial irradiation of the liver.
@ast
Partial irradiation of the liver.
@en
Partial irradiation of the liver.
@nl
type
label
Partial irradiation of the liver.
@ast
Partial irradiation of the liver.
@en
Partial irradiation of the liver.
@nl
prefLabel
Partial irradiation of the liver.
@ast
Partial irradiation of the liver.
@en
Partial irradiation of the liver.
@nl
P356
P1476
Partial irradiation of the liver
@en
P2093
R K Ten Haken
T S Lawrence
P304
P356
10.1053/SRAO.2001.23485
P577
2001-07-01T00:00:00Z